
Ogicef T 1000mg/125mg Injection
Marketer
Logimed Pharma Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ogicef T 1000mg/125mg Injection
Combiflox, a 1000mg/125mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a doctor's guidance; adhere rigorously to the prescribed schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation compromises efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms promptly. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and sufficient hydration accelerate recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Ogicef T 1000mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ogicef T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ogicef T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ogicef T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ogicef T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ogicef T 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam injection (Ogicef T 1000mg/125mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Ogicef T 1000mg/125mg Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ogicef T (1000mg/125mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Ogicef T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Ogicef T 1000mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ogicef T 1000mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should use the 1000mg/125mg Ogicef T Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration of the 1000mg/125mg Ogicef T Injection is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Ogicef T 1000mg/125mg Injection :
Omit doses of Ogicef T 1000mg/125mg Injection only after contacting your physician.
Facts to Know About Ogicef T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
